PL37

Ligand id: 7896

Name: PL37

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 8
Hydrogen bond donors 2
Rotatable bonds 20
Topological polar surface area 192.85
Molecular weight 518.16
XLogP 6.12
No. Lipinski's rules broken 2

Molecular properties generated using the CDK

Classification
Compound class Synthetic organic
IUPAC Name
1-ethoxycarbonyloxyethyl 2-[[2-[(2-amino-4-methylsulfanylbutyl)disulfanylmethyl]-3-phenylpropanoyl]amino]acetate
Synonyms
19-IIIa [3] | Debio 0827 [1] | Debio-0827
Comments
PL37 is an investigational, orally available, dual pro-drug inhibitor of neprilysin (a.k.a. neutral endopeptidase or NEP; MME) and aminopeptidase N (APN; ANPEP) [3]. NEP and APN are enkephalin catabolising enzymes (or enkephalinases). Dual ENKephalinase inhibitors such as this one have been ascribed the acronym DENK inhibitor (or DENKi).
PL37 is the non-stereo enantiomer of compound 15 in patent US8247609 [4]. Such dual inhibitors are suggested as a novel mechanism for the control of central and peripheral pain [5], via inhibition of enzymatic degradation of endogenous enkephalins. Such agents could replace the use of opiate analgesics.
Database Links
GtoPdb PubChem SID 315661093
PubChem CID 16123252
Search Google for chemical match using the InChIKey BJCNUZJDFWFVBY-UHFFFAOYSA-N
Search Google for chemicals with the same backbone BJCNUZJDFWFVBY
Search UniChem for chemical match using the InChIKey BJCNUZJDFWFVBY-UHFFFAOYSA-N
Search UniChem for chemicals with the same backbone BJCNUZJDFWFVBY